Cargando…

1319. Microbiology and Epidemiology of Pediatric Ventriculoperitoneal Shunt Infections

BACKGROUND: Infections complicate approximately 10% of ventriculoperitoneal (VP) shunts in children, with considerable associated morbidity and mortality. Recent guidelines for empiric treatment of VP shunt infections recommend use of vancomycin combined with an anti-pseudomonal beta-lactam, but are...

Descripción completa

Detalles Bibliográficos
Autores principales: Claunch, Kevin M, Adams, Daniel, Deperrior, Sarah, Rajnik, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678182/
http://dx.doi.org/10.1093/ofid/ofad500.1158
_version_ 1785150302050058240
author Claunch, Kevin M
Adams, Daniel
Deperrior, Sarah
Rajnik, Michael
author_facet Claunch, Kevin M
Adams, Daniel
Deperrior, Sarah
Rajnik, Michael
author_sort Claunch, Kevin M
collection PubMed
description BACKGROUND: Infections complicate approximately 10% of ventriculoperitoneal (VP) shunts in children, with considerable associated morbidity and mortality. Recent guidelines for empiric treatment of VP shunt infections recommend use of vancomycin combined with an anti-pseudomonal beta-lactam, but are based on low-quality evidence. We aimed to further characterize and update the microbiology of pediatric VP shunt infections using the U.S. Military Health System database. METHODS: Department of Defense beneficiaries less than 22 years-of-age admitted for VP shunt infection between Oct 1, 2008 and Sep 30, 2019 were included. VP shunt infection was defined using a combination of ICD-9-CM and ICD-10-CM codes, CPT codes for removal or replacement of a shunt (Table 1), and positive cultures from a normally sterile site (cerebrospinal fluid, blood, catheter tip, and peritoneum). Demographic data on age, sex, and year of admission were collected for each patient, as was microbiologic data including organism and specimen source. [Figure: see text] RESULTS: There were 32 qualifying admissions among 30 patients for VP shunt infection over the 10-year study period, with no discernable year-to-year trend identified. Half of all VP shunt infections occurred in patients less than 12 months of age (Table 2). Sixty-one unique positive cultures were identified among the 30 patients, 38 (62%) from CSF samples, and the remaining 23 (38%) from blood, peritoneum, and catheter tips (Figure 1). Coagulase-negative Staphylococcus (28%), Staphylococcus aureus (15%), and Enterococcus spp. (10%) were the leading causative pathogens (Figure 2). Enteric gram-negative rods accounted for 21% of positive cultures. Pseudomonas spp. were rarely isolated (3%), however, strict anaerobic pathogens made up 8% of positive cultures. [Figure: see text] [Figure: see text] [Figure: see text] CONCLUSION: Empiric antibiotic treatment of VP shunt infections in children should cover gram-positive cocci and enteric gram-negative rods but need not cover Pseudomonas spp. Existing guidelines do not recommend anaerobic coverage, however, these data indicate empiric anaerobic coverage is prudent, especially when an intra-abdominal VP shunt infection is suspected. DISCLOSURES: All Authors: No reported disclosures
format Online
Article
Text
id pubmed-10678182
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-106781822023-11-27 1319. Microbiology and Epidemiology of Pediatric Ventriculoperitoneal Shunt Infections Claunch, Kevin M Adams, Daniel Deperrior, Sarah Rajnik, Michael Open Forum Infect Dis Abstract BACKGROUND: Infections complicate approximately 10% of ventriculoperitoneal (VP) shunts in children, with considerable associated morbidity and mortality. Recent guidelines for empiric treatment of VP shunt infections recommend use of vancomycin combined with an anti-pseudomonal beta-lactam, but are based on low-quality evidence. We aimed to further characterize and update the microbiology of pediatric VP shunt infections using the U.S. Military Health System database. METHODS: Department of Defense beneficiaries less than 22 years-of-age admitted for VP shunt infection between Oct 1, 2008 and Sep 30, 2019 were included. VP shunt infection was defined using a combination of ICD-9-CM and ICD-10-CM codes, CPT codes for removal or replacement of a shunt (Table 1), and positive cultures from a normally sterile site (cerebrospinal fluid, blood, catheter tip, and peritoneum). Demographic data on age, sex, and year of admission were collected for each patient, as was microbiologic data including organism and specimen source. [Figure: see text] RESULTS: There were 32 qualifying admissions among 30 patients for VP shunt infection over the 10-year study period, with no discernable year-to-year trend identified. Half of all VP shunt infections occurred in patients less than 12 months of age (Table 2). Sixty-one unique positive cultures were identified among the 30 patients, 38 (62%) from CSF samples, and the remaining 23 (38%) from blood, peritoneum, and catheter tips (Figure 1). Coagulase-negative Staphylococcus (28%), Staphylococcus aureus (15%), and Enterococcus spp. (10%) were the leading causative pathogens (Figure 2). Enteric gram-negative rods accounted for 21% of positive cultures. Pseudomonas spp. were rarely isolated (3%), however, strict anaerobic pathogens made up 8% of positive cultures. [Figure: see text] [Figure: see text] [Figure: see text] CONCLUSION: Empiric antibiotic treatment of VP shunt infections in children should cover gram-positive cocci and enteric gram-negative rods but need not cover Pseudomonas spp. Existing guidelines do not recommend anaerobic coverage, however, these data indicate empiric anaerobic coverage is prudent, especially when an intra-abdominal VP shunt infection is suspected. DISCLOSURES: All Authors: No reported disclosures Oxford University Press 2023-11-27 /pmc/articles/PMC10678182/ http://dx.doi.org/10.1093/ofid/ofad500.1158 Text en © The Author(s) 2023. Published by Oxford University Press on behalf of Infectious Diseases Society of America. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Abstract
Claunch, Kevin M
Adams, Daniel
Deperrior, Sarah
Rajnik, Michael
1319. Microbiology and Epidemiology of Pediatric Ventriculoperitoneal Shunt Infections
title 1319. Microbiology and Epidemiology of Pediatric Ventriculoperitoneal Shunt Infections
title_full 1319. Microbiology and Epidemiology of Pediatric Ventriculoperitoneal Shunt Infections
title_fullStr 1319. Microbiology and Epidemiology of Pediatric Ventriculoperitoneal Shunt Infections
title_full_unstemmed 1319. Microbiology and Epidemiology of Pediatric Ventriculoperitoneal Shunt Infections
title_short 1319. Microbiology and Epidemiology of Pediatric Ventriculoperitoneal Shunt Infections
title_sort 1319. microbiology and epidemiology of pediatric ventriculoperitoneal shunt infections
topic Abstract
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678182/
http://dx.doi.org/10.1093/ofid/ofad500.1158
work_keys_str_mv AT claunchkevinm 1319microbiologyandepidemiologyofpediatricventriculoperitonealshuntinfections
AT adamsdaniel 1319microbiologyandepidemiologyofpediatricventriculoperitonealshuntinfections
AT deperriorsarah 1319microbiologyandepidemiologyofpediatricventriculoperitonealshuntinfections
AT rajnikmichael 1319microbiologyandepidemiologyofpediatricventriculoperitonealshuntinfections